IFF Divestment: CVC Acquisition Signals Ingredients Sector Consolidation

London, United Kingdom — 01 June 2026

International Flavors & Fragrances (IFF) has completed the sale of its Food Ingredients business to CVC Capital Partners for £3.4 billion, one of the largest transactions in the ingredients sector. This divestment is a strategic move for IFF, enabling it to streamline its portfolio and concentrate on higher-growth, higher-margin segments like flavours, fragrances, and biosciences. The proceeds of approximately £3.0 billion will be primarily directed towards debt reduction, share repurchases, and investment in core operations, as stated by IFF CEO Erik Fyrwald. This follows a multi-year restructuring effort, including previous asset sales since the 2021 merger with DuPont’s Nutrition & Biosciences business, reinforcing a trend among major ingredient players towards portfolio optimisation.

For CVC, this acquisition establishes an immediately scaled platform in the food ingredients market. The divested unit reported an estimated £2.6 billion in revenue for 2025, supplying critical ingredients such as texturants, emulsifiers, and sweetening solutions across diverse food and beverage applications. CVC's Managing Partner, Lorne Somerville, emphasised the business's robust market position, technical capabilities, and global footprint. This deal underscores continued private equity appetite for resilient food and nutrition assets with established market presence and alignment with long-term consumer trends, setting the stage for potential future growth initiatives.

Competitors, including Ingredion, Tate & Lyle, Kerry Group, and dsm-firmenich, whose portfolios overlap with the acquired business, will be reassessing their market strategies. The entry of a private equity firm as the principal owner for this substantial asset could reshape competitive dynamics, with industry observers closely monitoring CVC’s strategy regarding investment, portfolio expansion, or further acquisitions. Manufacturers should anticipate potential shifts in supply chain relationships, innovation priorities, and pricing structures as the new entity evolves under CVC ownership. IFF will retain a 10% ownership stake, suggesting a transition phase where continuity is key for existing customers.

What this means for United Kingdom

UK supplement and food manufacturers must evaluate potential adjustments in pricing and supply chain stability for texturants, emulsifiers, and sweetening solutions. Brand owners should prepare for potential reformulation windows if product specifications or innovation priorities change post-acquisition. The heightened private equity interest suggests more M&A, increasing pressure on smaller, independent ingredient suppliers who could become acquisition targets or face intensified competition. This may also create opportunities for agile UK-based ingredient suppliers to fill niche gaps or innovate in specific functional ingredients not prioritised by the larger, consolidated entity, impacting lead times and MOQs.

Ultimately, the IFF-CVC deal signals a continuing movement towards consolidation within the broader ingredients sector. It reflects an industry-wide trend where large enterprises are refining their portfolios for specialised growth, and private equity firms are deploying capital into established, high-revenue ingredient assets. The long-term implications will depend on CVC's strategic deployment of capital and its approach to managing and growing this significant food ingredients platform.

Many leading brands in this category are manufactured in partnership with Supplement Factory.